GREENLIGHT CAPITAL RE LTD
For the period ended Dec 31, 2024. Filed Mar 10, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 10, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Innovations Segment
Results for the Innovations segment were as follows:
| Year ended December 31, · 2024 · % Change · 2023 · % Change · 2022 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross premiums written | $94,725 | 6.9% | $88,602 | 74.6% | $50,739 | |||
| Net premiums written | $80,016 | (4.3)% | $83,608 | 76.7% | $47,328 | |||
| Net premiums earned | $86,352 | 20.3% | $71,769 | 116.3% | $33,184 | |||
| Net loss and LAE incurred | (51,939) | (44,855) | (23,151) | |||||
| Acquisition costs | (27,151) | (22,381) | (11,111) | |||||
| Other underwriting expenses | (3,682) | (2,760) | (1,946) | |||||
| Underwriting income (loss) | 3,580 | 1,773 | (3,024) | |||||
| Net investment income | 702 | (74.3)% | 2,732 | (72.3)% | 9,869 | |||
| Corporate and other expenses | (2,445) | (20.6)% | (3,080) | (10.8)% | (3,452) | |||
| Income before income taxes | $1,837 | $1,425 | $3,393 | |||||
| Underwriting ratios: | 2024 | % Point Change | 2023 | % Point Change | 2022 | |||
| Loss ratio | 60.1% | (2.4)% | 62.5% | (7.3)% | 69.8% | |||
| Acquisition cost ratio | 31.4% | 0.2% | 31.2% | (2.3)% | 33.5% | |||
| Composite ratio | 91.5% | (2.2)% | 93.7% | (9.6)% | 103.3% | |||
| Underwriting expenses ratio | 4.3% | 0.5% | 3.8% | (2.1)% | 5.9% | |||
| Combined ratio | 95.8% | (1.7)% | 97.5% | (11.7)% | 109.2% | |||
Gross premiums written by line of business were as follows:
| % Change | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2024 · 2023 · 2022 · 2024 to 2023 · 2023 to 2022 | ||||||||
| Casualty | $24,843 | 26.2% | $19,447 | 21.9% | $5,653 | 11.1% | 27.7% | 244.0% |
| Financial | 7,800 | 8.2% | 6,955 | 7.8% | 2,617 | 5.2% | 12.1% | 165.8% |
| Health | 4,631 | 4.9% | 3,998 | 4.5% | 7,201 | 14.2% | 15.8% | (44.5)% |
| Multiline | 47,311 | 49.9% | 50,490 | 57.0% | 30,816 | 60.7% | (6.3)% | 63.8% |
| Specialty | 10,140 | 10.8% | 7,712 | 8.8% | 4,452 | 8.8% | 31.5% | 73.2% |
| Total | $94,725 | 100.0% | $88,602 | 100.0% | $50,739 | 100.0% | 6.9% | 74.6% |
Gross premiums written in 2024 increased by $6.1 million or 6.9%, compared to 2023. The increase was predominantly attributable to: (i) growth from existing customers in the casualty line and (ii) new customers in our financial, health, multiline (new accounts in our Syndicate 3456) and specialty lines. This was partially offset by a non-renewed treaty and lower premium volume from certain existing customers in our multiline business.
Gross premiums written in 2023 increased by $37.9 million or 74.6%, compared to 2022. The increase was predominantly attributable to the casualty line driven by new business and accelerated growth with existing customers, coupled with growth in our multiline driven by new business from our Syndicate 3456. This was partially offset by a decrease in health line predominantly due to the non-renewal of a program.
Net Premiums Written
Ceded premiums written in 2024 was $14.7 million, resulting in net premiums written of $80.0 million, compared to $5.0 million and $83.6 million, respectively, in 2023. The increase in ceded premiums written of 194.5% was predominantly in the casualty line and, to a lesser extent, in the multiline and specialty lines driven by quota share reinsurance treaties with our assumed customers in which they share indirectly the underwriting risks through their captives or other platforms.
Ceded premiums written in 2023 was $5.0 million, resulting in net premiums written of $83.6 million, compared to $3.4 million and $47.3 million, respectively, in 2022. The increase in ceded premiums written was predominantly in the multiline business due to new assumed business.
Net premiums earned by line of business were as follows:
| % Change | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2024 · 2023 · 2022 · 2024 to 2023 · 2023 to 2022 | ||||||||
| Casualty | $18,705 | 21.7% | $13,332 | 18.6% | $3,890 | 11.7% | 40.3% | 242.7% |
| Financial | 5,499 | 6.4% | 5,076 | 7.1% | 655 | 2.0% | 8.3% | 675.0% |
| Health | 2,144 | 2.5% | 2,522 | 3.5% | 7,030 | 21.2% | (15.0)% | (64.1)% |
| Multiline | 51,669 | 59.8% | 44,533 | 62.1% | 19,080 | 57.5% | 16.0% | 133.4% |
| Specialty | 8,335 | 9.6% | 6,306 | 8.7% | 2,529 | 7.6% | 32.2% | 149.3% |
| Total | $86,352 | 100.0% | $71,769 | 100.0% | $33,184 | 100.0% | 20.3% | 116.3% |
Net premiums earned in 2024 increased by $14.6 million or 20.3%, compared to 2023. Further, net premiums earned in 2023 increased by $38.6 million or 116.3%, compared to 2022. The increase in net premiums by line of business is relatively consistent with the trends noted for the gross premiums written. The change is also influenced by the amount and timing of net premiums written during the current year and prior years, coupled with the business mix written in the form of excess of loss versus proportional contracts.
Loss ratio
The components of the loss ratio were as follows:
| Year ended December 31, | 2024 | % Point Change | 2023 | % Point Change | 2022 |
|---|---|---|---|---|---|
| Current year: | |||||
| Attritional loss ratio | 60.5% | (1.4)% | 61.9% | 0.2% | 61.7% |
| CAT losses | —% | —% | —% | —% | —% |
| Current year loss ratio | 60.5% | (1.4)% | 61.9% | 0.2% | 61.7% |
| Prior year reserve development ratio | (0.3)% | (0.9)% | 0.6% | (7.4)% | 8.0% |
| Loss ratio | 60.1% | (2.4)% | 62.5% | (7.3)% | 69.8% |
Current Year Loss Ratio
The current year loss ratio in 2024 decreased by 1.4%, compared to 2023 driven mainly by modest lower attritional loss ratio in our casualty, multiline and specialty lines due to new business; offset predominantly by a 2023 quota share reinsurance program in financial lines, which we did not renew but continued to earn premiums in 2024.
The current year loss ratio in 2023 increased marginally by 0.2%, compared to 2022.
The Innovations segment was not impacted by any CAT events for the years presented in the above table.
Prior Year Reserve Development Ratio
Prior year reserve development ratio improved by 0.9% in 2024 compared to 2023, and by 7.4% in 2023 compared to 2022. Refer to Note 7 Loss and LAE Reserves to the consolidated financial statements for further details on the lines of business and prior year development.
Acquisition cost ratio
The acquisition cost ratio increased marginally by 0.2% to 31.4% in 2024 compared to 2023.We had lower acquisition costs predominantly from the financial line due to lower profit commission relating to a non-renewed program; offset mainly by new accounts in the multiline business, within our Syndicate 3456, at higher acquisition costs.
The acquisition cost ratio decreased by 2.3% to 31.2% in 2023 compared to 2022, primarily due to growth in net premiums earned from our Syndicate 3456 (included in multiline) to cover fixed acquisition costs, coupled with a change in business mix with growth in our casualty and specialty lines due to new accounts at lower acquisition costs.
Underwriting expense ratio
The underwriting expense ratio increased by 0.5% to 4.3% in 2024 compared to 2023, mainly due to an increase in personnel and overhead costs to support the Innovations business growth; partially offset by the 20.3% increase in net premiums earned to cover fixed costs.
The underwriting expense ratio decreased by 2.1% to 3.8% in 2023 compared to 2022, mainly due to the 116.3% increase in net premiums earned to cover fixed costs, partially offset by an increase in personnel costs to support the Innovations business growth.
Income before income taxes
The income before income taxes for Innovations was $1.8 million in 2024 compared to $1.4 million in 2023. The increase was mainly due to an increase in underwriting income, partially offset by lower net investment income driven by net downward valuation adjustments relating to certain Innovations private investments.
The income before income taxes for Innovations was $1.4 million in 2023 compared to $3.4 million in 2022. The decrease was driven by a decrease in net investment income mainly due to lower unrealized gains from our Innovations private investments, in part due to less favorable pricing conditions from financing rounds completed by our investees. This was partially offset by improved underwriting performance and lower Innovations-related expenses.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.